JPX · 4506.T
Sumitomo Pharma Co., Ltd.
¥1,885-¥61 (-3.11%)
Sumitomo Pharma Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 42.69% below the high.
Loading market information…
JPX · 4554.T · JPY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 06:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · JPY. Historical prices are not a forecast.
Fuji Pharma Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 26.92% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Fuji Pharma Co., Ltd.’s forward annual dividend is ¥52 per share, paid semi-annual. The forward yield is 2.78% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Fuji Pharma Co., Ltd.’s next earnings report is currently expected on Nov 10, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Fuji Pharma Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Fuji Pharma Co., Ltd. is a pharmaceutical company that operates globally, focusing on the complete spectrum of drug development, from initial research and discovery through manufacturing and commercialization. Its comprehensive product line includes various medical solutions such as injectable medications, oral therapeutics, topical treatments, and a range of diagnostic tools. Beyond its core pharmaceutical offerings, Fuji Pharma also specializes in women's healthcare products, advanced in vitro diagnostic technologies, and acute medical intervention solutions. The company further contributes by disseminating valuable pharmaceutical and general health information. Founded in 1965, Fuji Pharma Co., Ltd. has its corporate headquarters located in Tokyo, Japan.
Latest available per-share figures in JPY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 11:09 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| ¥13B+16.14% vs estimate |
| Q4 2024 | Nov 12, 2024 | ¥51 | ¥12.98B+6.42% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
¥1,885-¥61 (-3.11%)
Sumitomo Pharma Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 42.69% below the high.
¥3,436+¥18 (+0.53%)
Nippon Shinyaku Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 47.37% below the high.
¥3,520+¥60 (+1.73%)
Towa Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 21.6% below the high.
¥1,977+¥36 (+1.85%)
Zeria Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 18.78% below the high.
¥1,986-¥1 (-0.05%)
ASKA Pharmaceutical Holdings Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 34.78% below the high.
¥1,323+¥19 (+1.46%)
Daito Pharmaceutical Co.,Ltd.’s quoted price sits in the upper half of its reported 52-week range, 13.02% below the high.
¥839+¥9 (+1.08%)
Koa Shoji Holdings Co.,Ltd.’s quoted price sits in the upper half of its reported 52-week range, 8.71% below the high.
¥635-¥1 (-0.16%)
Pharma Foods International Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 23.12% below the high.
